MSB 8.43% $1.35 mesoblast limited

Pick Today's Price Range Low-High... Just for Fun, page-165

  1. 6,935 Posts.
    lightbulb Created with Sketch. 1523
    We will over-taking Novartis in sales of Remestemcel-L compared to Ruxolitnib.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.